![\"Veterinary](\"https:\/\/agribrasilis.com\/wp-content\/uploads\/2022\/07\/bolis.jpg\")
Delair Bolis<\/strong> is president of MSD Animal Health in Brazil, Paraguay, Uruguay and Bolivia.<\/p><\/div>\n AgriBrasilis – What is the size of the animal pharmaceuticals market (market growth numbers and MSD)?<\/strong><\/p>\n Delair Bolis – <\/strong>The animal health market is one of the most promising, contributing directly to the care of animals and consequently of people around the world.<\/p>\n According to a survey by Sindan, the estimated growth of the veterinary industry in 2021 was 9.2%.<\/p>\n MSD Animal Health also had good results, following this movement. Despite being a year that continued to challenge everyone, the company bet even more on a new horizon in the sector, achieving 29% growth compared to 2020, which was 21% more than the company had planned, reaching revenues equivalent to US$ 260 million (2020 revenue was around US$ 216 million).<\/p>\n We believe in an optimistic year of growth. In 2022 we will launch 12 new products, serving the livestock, swine, aquaculture, poultry and pet markets. We will maintain our investment strategy in the country, seeking to achieve our goal of exceeding US$ 400 million in revenues in 2023.<\/p>\n AgriBrasilis – How have animal welfare concerns affected the market and consumer choices?<\/strong><\/p>\n
\n